Journal
JOURNAL OF HETEROCYCLIC CHEMISTRY
Volume 55, Issue 12, Pages 2715-2721Publisher
WILEY
DOI: 10.1002/jhet.3328
Keywords
-
Categories
Funding
- UGC
- CSIR, New Delhi [BSC-0106, BSC-209]
Ask authors/readers for more resources
In this study, a series of new alantolactone (AL) amino scaffolds (AL1-AL13) had been synthesized and evaluated for in vitro cytotoxicity against three human cancer cell lines: human cervical cancer (SiHa), human epidermoid carcinoma (KB), and human lung cancer (A549). The compounds AL 2, 4, 5, 7, and 13 were found to be nearly as equally active as AL against three tested cell lines, whereas AL 1 and 12 against SiHa cells. This study also provides a correlation on the structure activity relationship of AL and derivatized analogues against tested cells. The retention of cytotoxicity with enhanced water solubility in derivatized amino adducts including AL 1, 2, 4, 5, 7, 12, and 13 indicates that these adducts can further be tested for the detailed in vivo safety and anticancer studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available